• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期喉癌治疗中全喉切除术与非手术器官保留策略的疗效比较:一项荟萃分析。

Efficacy comparison between primary total laryngectomy and nonsurgical organ-preservation strategies in treatment of advanced stage laryngeal cancer: A meta-analysis.

作者信息

Tang Zhao-Xian, Gong Jing-Lin, Wang Ya-Hui, Li Zhen-Hua, He Yun, Liu Yi- Xiu, Zhou Xiao-Hong

机构信息

Department of ENT, Chongqing Cancer Hospital and Institute and Cancer Center, Chongqing, China.

出版信息

Medicine (Baltimore). 2018 May;97(21):e10625. doi: 10.1097/MD.0000000000010625.

DOI:10.1097/MD.0000000000010625
PMID:29794737
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6392597/
Abstract

BACKGROUND

We aimed to provide a pooled analysis of controlled trials comparing long-term survival after primary laryngectomy and primary organ preservation methods in patients with T3-4 laryngeal cancer.

METHODS

We performed random-effects meta-analyses on overall survival (OS), disease-free survival (DFS), disease-specific survival (DSS), and locoregional control (LRC).

RESULTS

Fifteen studies met the selection criteria including 6288 patients (2696 patients who underwent primary laryngectomy and 3592 patients who underwent primary nonsurgical organ preservation therapy). There was a significant difference between the groups with respect to OS (HR 0.71, 95% CI 0.57-0.89, P = .003). However, a subgroup analysis found OS was not significantly worse for patients with T3 laryngeal cancer who received primary organ preservation compared with patients who underwent primary laryngectomy (HR 0.96, 95% CI 0.45-2.03, P = .91). There was no significant difference for DFS (HR 0.63, 95% CI 0.39-1.04, P = .07) in two groups. Patients with laryngeal cancer who underwent primary laryngectomy had a better DSS (HR 0.47, 95% CI 0.25-0.88, P = .02) and LRC (HR 0.56, 95% CI 0.390.80, P = .001) than patients who underwent primary nonsurgical organ preservation therapy.

CONCLUSION

Our results support total laryngectomy for patients with T4 laryngeal cancer and show that primary organ preservation for laryngeal cancer has no advantage and also did not decrease the rate of OS in patients with T3 laryngeal cancer when compared with primary total laryngectomy.

摘要

背景

我们旨在对比较T3-4期喉癌患者行初次喉切除术和初次器官保留治疗后的长期生存率的对照试验进行汇总分析。

方法

我们对总生存期(OS)、无病生存期(DFS)、疾病特异性生存期(DSS)和局部区域控制(LRC)进行随机效应荟萃分析。

结果

15项研究符合入选标准,包括6288例患者(2696例行初次喉切除术的患者和3592例行初次非手术器官保留治疗的患者)。两组在OS方面存在显著差异(风险比[HR] 0.71,95%置信区间[CI] 0.57 - 0.89,P = 0.003)。然而,亚组分析发现,与行初次喉切除术的患者相比,接受初次器官保留治疗的T3期喉癌患者的OS并无显著更差(HR 0.96,95% CI 0.45 - 2.03,P = 0.91)。两组在DFS方面无显著差异(HR 0.63,95% CI 0.39 - 1.04,P = 0.07)。行初次喉切除术的喉癌患者比接受初次非手术器官保留治疗的患者具有更好的DSS(HR 0.47,95% CI 0.25 - 0.88,P = 0.02)和LRC(HR 0.56,95% CI 0.39 - 0.80,P = 0.001)。

结论

我们的结果支持对T4期喉癌患者行全喉切除术,并表明与初次全喉切除术相比,喉癌的初次器官保留治疗没有优势,也未降低T3期喉癌患者的OS率。

相似文献

1
Efficacy comparison between primary total laryngectomy and nonsurgical organ-preservation strategies in treatment of advanced stage laryngeal cancer: A meta-analysis.晚期喉癌治疗中全喉切除术与非手术器官保留策略的疗效比较:一项荟萃分析。
Medicine (Baltimore). 2018 May;97(21):e10625. doi: 10.1097/MD.0000000000010625.
2
Efficacy Comparison Between Total Laryngectomy and Nonsurgical Organ-Preservation Modalities in Treatment of Advanced Stage Laryngeal Cancer: A Meta-Analysis.全喉切除术与非手术器官保留模式治疗晚期喉癌的疗效比较:一项Meta分析
Medicine (Baltimore). 2016 Apr;95(14):e3142. doi: 10.1097/MD.0000000000003142.
3
Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.比较局部晚期喉癌全喉切除术与手术和非手术保喉治疗。
Cancer. 2019 Oct 1;125(19):3367-3377. doi: 10.1002/cncr.32292. Epub 2019 Jun 17.
4
A change in the study evaluation paradigm reveals that larynx preservation compromises survival in T4 laryngeal cancer patients.研究评估范式的改变表明,T4 期喉癌患者的喉保留会影响生存。
BMC Cancer. 2017 Sep 1;17(1):609. doi: 10.1186/s12885-017-3608-7.
5
Oncological and functional outcomes in T3 and T4 laryngeal cancer patients: choice for larynx preservation or total laryngectomy based on expected laryngeal function.T3 和 T4 喉癌患者的肿瘤学和功能预后:基于预期喉功能选择保留喉或全喉切除术。
J Laryngol Otol. 2024 Jun;138(6):672-678. doi: 10.1017/S0022215124000112. Epub 2024 Jan 18.
6
Comparison of total laryngectomy with surgical (cricohyoidopexy) and nonsurgical organ-preservation modalities in advanced laryngeal squamous cell carcinomas: A multicenter retrospective analysis.在晚期喉鳞状细胞癌中,全喉切除术与手术(环舌骨固定术)和非手术器官保留方式的比较:一项多中心回顾性分析。
Head Neck. 2013 Apr;35(4):554-61. doi: 10.1002/hed.22994. Epub 2012 Apr 12.
7
Survival outcomes in advanced laryngeal cancer.晚期喉癌的生存结果。
JAMA Otolaryngol Head Neck Surg. 2014 Sep;140(9):855-60. doi: 10.1001/jamaoto.2014.1671.
8
Comparison of the therapeutic effects of total laryngectomy and a larynx-preservation approach in patients with T4a laryngeal cancer and thyroid cartilage invasion: A multicenter retrospective review.全喉切除术与保喉术式治疗T4a期喉癌侵犯甲状腺软骨患者的疗效比较:一项多中心回顾性研究
Head Neck. 2016 Aug;38(8):1271-7. doi: 10.1002/hed.24438. Epub 2016 Apr 4.
9
Primary Total Laryngectomy versus Organ Preservation for Locally Advanced T3/T4a Laryngeal Cancer.局部晚期T3/T4a喉癌的全喉切除术与器官保留治疗对比
Laryngoscope. 2023 May;133(5):1122-1131. doi: 10.1002/lary.30254. Epub 2022 Jun 26.
10
Utility of bioselection with neoadjuvant chemotherapy for organ preservation in patients with T4 laryngeal cancer.新辅助化疗的生物选择在 T4 期喉癌患者器官保留中的作用。
Oral Oncol. 2024 Sep;156:106917. doi: 10.1016/j.oraloncology.2024.106917. Epub 2024 Jun 28.

引用本文的文献

1
Guidelines for the Treatment of Laryngeal Cancer from the Korean Society of Head and Neck Surgery.韩国头颈外科学会喉癌治疗指南
Clin Exp Otorhinolaryngol. 2025 May;18(2):89-108. doi: 10.21053/ceo.2025.00009. Epub 2025 Apr 8.
2
Long-Term Quality of Life and Functional Outcomes in Patients with Total Laryngectomy.全喉切除患者的长期生活质量和功能结局
Cancers (Basel). 2025 Mar 17;17(6):1011. doi: 10.3390/cancers17061011.
3
Global, regional, and national mortality of larynx cancer from 1990 to 2021: results from the global burden of disease study.

本文引用的文献

1
Predictive and prognostic factors for patients with locoregionally advanced laryngeal carcinoma treated with surgical multimodality protocol.采用手术多模式方案治疗的局部区域晚期喉癌患者的预测和预后因素。
Eur Arch Otorhinolaryngol. 2017 Mar;274(3):1701-1711. doi: 10.1007/s00405-016-4411-9. Epub 2016 Dec 10.
2
Clinical outcomes in patients with T4 laryngeal cancer treated with primary radiotherapy versus primary laryngectomy.T4期喉癌患者接受根治性放疗与根治性喉切除术的临床结局
Head Neck. 2016 Apr;38 Suppl 1:E2035-40. doi: 10.1002/hed.24374. Epub 2016 Feb 1.
3
Trends in treatment and survival for advanced laryngeal cancer: A 20-year population-based study in The Netherlands.
1990年至2021年全球、区域和国家喉癌死亡率:全球疾病负担研究结果
World J Surg Oncol. 2025 Mar 7;23(1):76. doi: 10.1186/s12957-025-03720-6.
4
Investigating the Incidence and Risk Factors of Hypocalcemia After Laryngectomy.喉切除术后低钙血症的发病率及危险因素调查
Indian J Otolaryngol Head Neck Surg. 2024 Oct;76(5):4096-4101. doi: 10.1007/s12070-024-04790-w. Epub 2024 Jul 23.
5
Total laryngectomy vs. non-surgical organ preservation in advanced laryngeal cancer: a metanalysis.全喉切除术与非手术性器官保留在晚期喉癌中的比较:一项荟萃分析。
Braz J Otorhinolaryngol. 2024 May-Jun;90(3):101404. doi: 10.1016/j.bjorl.2024.101404. Epub 2024 Feb 21.
6
Unlocking tracheoesophageal speech from pharyngoesophageal spasm: preliminary results of a videofluoroscopic-guided botulinum toxin A injection technique.从咽食管痉挛中解锁气管食管语音:视频荧光镜引导下肉毒杆菌毒素A注射技术的初步结果。
Eur Arch Otorhinolaryngol. 2024 Apr;281(4):1885-1893. doi: 10.1007/s00405-024-08448-9. Epub 2024 Jan 27.
7
Oncological and functional outcomes in T3 and T4 laryngeal cancer patients: choice for larynx preservation or total laryngectomy based on expected laryngeal function.T3 和 T4 喉癌患者的肿瘤学和功能预后:基于预期喉功能选择保留喉或全喉切除术。
J Laryngol Otol. 2024 Jun;138(6):672-678. doi: 10.1017/S0022215124000112. Epub 2024 Jan 18.
8
Survival Outcomes in T3 Laryngeal Cancers: Primary Total Laryngectomy vs. Concurrent Chemoradiation or Radiation Therapy-A Meta-Analysis.T3期喉癌的生存结果:原发性全喉切除术与同步放化疗或放射治疗的荟萃分析
Biomedicines. 2023 Jul 28;11(8):2128. doi: 10.3390/biomedicines11082128.
9
Overview of glottic laryngeal cancer treatment recommendation changes in the NCCN guidelines from 2011 to 2022.NCCN 指南中 2011 年至 2022 年声门型喉癌治疗推荐变化概述。
Cancer Rep (Hoboken). 2023 Aug;6(8):e1837. doi: 10.1002/cnr2.1837. Epub 2023 Jun 7.
10
Treatment Results for Stage III Laryngeal Cancer: Analysis of a Populational Database Using Propensity Scores.III期喉癌的治疗结果:使用倾向评分对人群数据库的分析
Int Arch Otorhinolaryngol. 2021 Nov 3;26(3):e370-e379. doi: 10.1055/s-0041-1726042. eCollection 2022 Jul.
晚期喉癌的治疗与生存趋势:荷兰一项基于人群的20年研究。
Head Neck. 2016 Apr;38 Suppl 1:E1247-55. doi: 10.1002/hed.24200. Epub 2015 Aug 28.
4
Total Laryngectomy Versus Larynx Preservation for T4a Larynx Cancer: Patterns of Care and Survival Outcomes.T4a期喉癌的全喉切除术与喉保留术:治疗模式与生存结果
Int J Radiat Oncol Biol Phys. 2015 Jul 1;92(3):594-601. doi: 10.1016/j.ijrobp.2015.03.004.
5
Treatment Selection for T3/T4a Laryngeal Cancer: Chemoradiation Versus Primary Surgery.T3/T4a期喉癌的治疗选择:放化疗与原发手术对比
Ann Otol Rhinol Laryngol. 2015 Nov;124(11):845-51. doi: 10.1177/0003489415588130. Epub 2015 May 19.
6
Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3-decade survey.喉T4期鳞状细胞癌患者手术或非手术初始治疗后的长期预后:一项为期30年的调查。
Cancer. 2015 May 15;121(10):1608-19. doi: 10.1002/cncr.29241. Epub 2015 Jan 13.
7
T3-T4 laryngeal cancer in The Netherlands Cancer Institute; 10-year results of the consistent application of an organ-preserving/-sacrificing protocol.荷兰癌症研究所的T3 - T4期喉癌;器官保留/牺牲方案持续应用的10年结果
Head Neck. 2015 Oct;37(10):1495-503. doi: 10.1002/hed.23789. Epub 2014 Oct 10.
8
Management of locally advanced laryngeal cancer.局部晚期喉癌的治疗。
J Otolaryngol Head Neck Surg. 2014 Jan 28;43(1):4. doi: 10.1186/1916-0216-43-4.
9
Cancer statistics, 2014.癌症统计数据,2014 年。
CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29. doi: 10.3322/caac.21208. Epub 2014 Jan 7.
10
Tumor volumetry as a prognostic factor in the management of T4a laryngeal cancer.肿瘤体积作为 T4a 喉癌治疗中预后因素的研究。
Laryngoscope. 2014 May;124(5):1134-40. doi: 10.1002/lary.24461. Epub 2013 Nov 19.